Efaproxiral-d6

CAT: 0804-HY-13619S-01Size: 10 mgDry Ice: NoHazardous: No
CAT#:0804-HY-13619S-01Size:10 mg
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Efaproxiral-d6 is the deuterium labeled Efaproxiral. Efaproxiral (RSR13) is a haemoglobin (Hb) synthetic allosteric modifier, decreases Hb-oxygen (O2) binding affinity and enhances oxygenation of hypoxic tumours during radiation therapy[1][2].
CAS Number
[1246815-16-6]
UNSPSC
12352005
Target
Isotope-Labeled Compounds; Reactive Oxygen Species (ROS)
Type
Isotope-Labeled Compounds
Related Pathways
Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB; Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Solubility
10 mM in DMSO
Smiles
O(C(C(O)=O)(C([2H])([2H])[2H])C([2H])([2H])[2H])C1=CC=C(CC(NC2=CC(C)=CC(C)=C2)=O)C=C1
Molecular Formula
C20H17D6NO4
Molecular Weight
347.44
References & Citations
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53 (2) :211-216.|[2]Stea B, et al. Efaproxiral red blood cell concentration predicts efficacy in patients with brain metastases. Br J Cancer. 2006 Jun 19;94 (12) :1777-1784.|[3]Abraham DJ, et al. Allosteric modifiers of hemoglobin: 2-[4-[[ (3,5-disubstituted anilino) carbonyl]methyl]phenoxy]-2-methylpropionic acid derivatives that lower the oxygen affinity of hemoglobin in red cell suspensions, in whole blood, and in vivo in rats. Biochemistry. 1992 Sep 29;31 (38) :9141-9.|[4]Hou H, et al. The effects of Efaproxyn (efaproxiral) on subcutaneous RIF-1 tumor oxygenation and enhancement of radiotherapy-mediated inhibition of tumor growth in mice. Radiat Res. 2007 Aug;168 (2) :218-25.|[5]Hou H, et al. Increased oxygenation of intracranial tumors by efaproxyn (efaproxiral), an allosteric hemoglobin modifier: In vivo EPR oximetry study. Int J Radiat Oncol Biol Phys. 2005 Apr 1;61 (5) :1503-9.
Shipping Conditions
Room temperature
Scientific Category
Isotope-Labeled Compounds
Clinical Information
No Development Reported

Related Products

CatalogName
HY-13619-01Efaproxiral
HY-13619A-01Efaproxiral (sodium)
HY-13619R-01Efaproxiral (Standard)
HY-13619AR-01Efaproxiral (sodium) (Standard)
HY-110225-01Levetiracetam-d6 (ring-d6)
HY-B1849S-01Hexazinone-d6
HY-14264S-01Cyamemazine-d6
HY-B1114S-01Gliquidone-d6
HY-10261S-01Afatinib-d6
HY-N0113S-01Hordenine-d6

Alternative Products

CatalogName
TRC-E415002-5MGEfaproxiral-d6
274874-01Efaproxiral
A12323-5Efaproxiral 5mg
BUP16671-01Efaproxiral Sodium
A12323-50Efaproxiral 50mg
A12323-200Efaproxiral 200mg
A12323-10Efaproxiral 10mg
A12323-25Efaproxiral 25mg

Popular Products